BioView Information

BioView develops, manufactures, and markets innovative automated cell imaging and analysis platforms for clinical and research laboratories in cytology, cytogenetics, and pathology. Our solutions enable laboratories to digitize, standardize, and streamline complex diagnostic workflows using advanced fluorescent and bright-field imaging combined with artificial intelligence. Our platforms support a wide range of applications, including automated FISH analysis of tissue and cell suspensions for cancer and genetic abnormalities, whole-slide imaging for digital pathology, and quantitative IHC scoring for nuclear and membrane staining. In cytogenetics, our AI-powered Karyotyping platform uses deep learning to significantly improve laboratory efficiency and productivity, featuring advanced supervisor monitoring tools and an automated ISCN results generator connected to an online cytogenetics database. BioView is also a global leader in circulating tumor cell (CTC) detection, enumeration, and characterization. Our all-in-one system delivers high speed, sensitivity, and standardization, integrating with virtually any CTC enrichment method and supporting flexible combinations of immunofluorescence and FISH markers. Our customers leverage both offline and web-based analysis tools to collaborate with colleagues, share data, and advance research and diagnostic capabilities worldwide.